Clinical trial
A Comparative Study on the Efficacy and Safety of E3810 in Patients With…
NCT00165646 · Eisai Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00165646 |
|---|---|
| Title | A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease |
| Official title | A Double-Blind, Placebo-Controlled, Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease |
| Lead sponsor | Eisai Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-erosive Gastroesophageal Reflux Disease |
| Intervention type | Drug |
| Interventions | E3810, Placebo |
| Enrollment | 288 |
| Start date | Sep 1, 2004 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Sep 14, 2005 |
| Last update posted | Jul 18, 2011 |
| Countries | Japan |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: